The Longevity Podcast: Optimizing HealthSpan & MindSpan

Depression Or Dementia First

Dung Trinh

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 16:49

Send us Fan Mail

Depression and dementia get talked about like two separate problems, until you ask the uncomfortable question: which one comes first? We dig into a huge 22-year longitudinal study (over 13,000 Americans in the Health and Retirement Study) to figure out whether depressive symptoms are a modifiable dementia risk factor or an early clinical warning sign of Alzheimer’s disease and related neurodegenerative pathology.

The timeline turns out to be the tell. When depressive symptoms show up in late midlife (ages 50 to 59), dementia risk jumps dramatically, and the relationship holds even after researchers exclude people who develop dementia within the next 5 or 10 years. That pattern fits a long-run “rust” model, where chronic HPA axis activation, cortisol exposure, inflammation, and vascular damage slowly reduce brain resilience and cognitive reserve. When depression appears later (60+), the association fades with lag tests, pointing toward a prodrome like a check engine light rather than decades of wear-and-tear.

Then the genetics twist lands: depression predicts incident dementia most strongly in people with lower Alzheimer’s polygenic risk scores, while it barely moves the needle for those with high genetic risk. We also unpack a Markov model of cognitive stages, including the controversial gray zone of subjective memory complaint, and why new depression during that stage can matter so much clinically.

If you care about dementia prevention, mental health, or aging well, this conversation gives you a clearer map for action by age and risk profile. Subscribe for more deep dives, share this with someone navigating depression or memory worries, and leave a review with your biggest takeaway.

This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice. 

Never miss an episode—subscribe on your favorite podcast app!

Depression Versus Dementia Question

SPEAKER_00

Today, we are trying to solve, honestly, the ultimate chicken or egg mystery in neurology.

SPEAKER_01

Oh, it is a massive one. We've been debating this for decades.

SPEAKER_00

Right. And the question is basically: does depression cause dementia, or is it just the first warning sign of a brain that is already in decline?

SPEAKER_01

Aaron Ross Powell Exactly. I mean, depending on which scenario is actually true, it entirely changes how doctors approach treatment and you know counseling for aging patients with mood disorders.

SPEAKER_00

Aaron Powell Yeah, because we have to know if we're looking at a modifiable cause that we can fight or just a biological alarm bell that we need to prepare for.

SPEAKER_01

Right,

The 22-Year Data Set

SPEAKER_01

exactly.

SPEAKER_00

So to finally untangle this web, we're taking a deep dive into a massive 22-year longitudinal study. This was published in the Journal of Prevention of Alzheimer's disease in 2026.

SPEAKER_01

It's an incredible data set, honestly.

SPEAKER_00

Yeah, the researchers analyzed data from the Health and Retirement Study, tracking over 13,000 Americans from 1998 all the way to 2020.

SPEAKER_01

And just to give you a sense of the sheer scale here and the clinical stakes, at the baseline of this study, about 11.3% of the participants had elevated depressive symptoms.

SPEAKER_00

Aaron Powell And they measured that with something specific.

SPEAKER_01

Yeah, the eight-item CESD scale. Which is important because it doesn't just ask, you know, are you feeling sad?

SPEAKER_00

Right.

SPEAKER_01

It tracks physical markers, things like sleep disruption, chronic fatigue, pervasive hopelessness. And over those two decades of follow-up, about 20% of the total group went on to develop incident dementia.

SPEAKER_00

Aaron Powell Okay, let's unpack this for a second because just looking at a giant spreadsheet of depressed patients, well, it isn't enough to establish how this actually works.

SPEAKER_01

Aaron Powell No, definitely not.

SPEAKER_00

The researchers had to use two specific keys to unlock this mystery. The first key was the timeline like the age when the depression hit. And the second key was the individual's genetic blueprint.

SPEAKER_01

Aaron Powell Right. And if we connect this to the bigger picture, isolating the when and the why of this transition, it could fundamentally alter our timeline for cognitive preservation.

SPEAKER_00

Aaron Powell makes total sense.

SPEAKER_01

I mean, identifying depression as an active mechanism of damage means we can intervene decades early, but recognizing it as a prodrome-like, an early clinical manifestation that shifts the focus to managing the progression.

SPEAKER_00

Time really is the ultimate lie detector here. I like to visualize the distinction kind of like this. Is depression a long-term risk factor-like living near the ocean where the salt air causes this slow, imperceptible rust on your car over 20 years?

SPEAKER_01

Oh, I like that analogy.

SPEAKER_00

Or is it a prodrome, you know, like the check engine light flicking on just a few miles before the transmission fails entirely?

SPEAKER_01

That's a great way to put it. And the study's first major finding gives

Midlife Spike And Lag Tests

SPEAKER_01

us a massive clue to separate the rest from the check engine light.

SPEAKER_00

Aaron Powell, What do they find?

SPEAKER_01

Well, looking at the overall data, having baseline depressive symptoms increased a person's risk of developing dementia by 24%.

SPEAKER_00

Wow, okay.

SPEAKER_01

Which is a significant jump in the hazard ratio. But the moment they segmented the participants by age, this striking divergence popped up.

SPEAKER_00

Aaron Powell Right, because for people in late midlife, which they defined as ages 50 to 59, having depressive symptoms increased their dementia risk by a massive 65%.

SPEAKER_01

Aaron Powell Yeah, 65% is huge.

SPEAKER_00

Aaron Powell But for those 60 and older, the increase was only 19%. Which honestly feels a bit backward to me.

SPEAKER_01

How so?

SPEAKER_00

Well, you usually assume the older demographic is way more vulnerable to like almost every compounding health risk.

SPEAKER_01

Aaron Powell you'd think so, yeah. But the biological context clears up that paradox. To definitively prove whether that midlife spike was a long-term cause or just an early symptom, the researchers used a five and ten year lag analysis. Aaron Powell Okay.

SPEAKER_00

What does that mean?

SPEAKER_01

Aaron Powell Basically, they re-ran their entire statistical model, but they intentionally excluded any participant who developed dementia within the first five years and then the first ten years after their depression screening.

SPEAKER_00

Aaron Powell Wait, they just threw out the first 10 years of data?

SPEAKER_01

They did, yeah.

SPEAKER_00

If I read a study that just deleted a decade of outcomes because it complicated things, I'd call that cherry-picking data to fit a narrative. How is that scientifically valid?

SPEAKER_01

Aaron Powell I know, I know. It sounds like statistical manipulation until you realize what they're trying to isolate.

SPEAKER_00

Okay.

SPEAKER_01

Think back to your car analogy. A prodrome, the check engine light, only flashes right before the breakdown.

SPEAKER_00

Right.

SPEAKER_01

So if depression is merely a symptom of impending dementia, it shouldn't predict a dementia diagnosis twenty years down the line. It should only correlate with cases that emerge shortly after the depression begins. Oh, I see. By stripping out anyone who developed dementia within a decade, they essentially filtered out the immediate noise. They wanted to see if long-term structural damage was occurring.

SPEAKER_00

So they ignored the cars that broke down immediately to see if the slow-moving rust was actually destroying the vehicles decades later.

SPEAKER_01

Exactly. And the results of that lag test were staggering.

SPEAKER_00

What happened?

SPEAKER_01

When they excluded anyone who developed dementia within 10 years, that strong 65% elevated risk for the 50 to 59 group, it stayed incredibly robust.

SPEAKER_00

Wow.

SPEAKER_01

The statistical link barely wavered. But for the 60 plus group, the association practically vanished. It attenuated to the point of no longer being statistically significant.

SPEAKER_00

Aaron Ross Powell That is wild to consider. So what that means for you listening right now is that midlife depression, like in your 50s, behaves as a long-term physical risk

How Depression Damages The Brain

SPEAKER_00

factor. It is the rust.

SPEAKER_01

Yes, exactly. We are talking about chronic HPA axis activation.

SPEAKER_00

Aaron Powell The HPA axis being the brain's central stress response system.

SPEAKER_01

Aaron Powell Right. When you are chronically depressed, your HPA axis goes into overdrive. It constantly floods your brain with cortisol.

SPEAKER_00

Trevor Burrus And over decades, that toxic cortisol exposure physically shrinks the hippocampus, right? The brain's memory center.

SPEAKER_01

Trevor Burrus It does. Combine that with the systemic inflammation and the vascular damage that comes with long-term depression, and you're actively eroding the brain's resilience. The depression is physically wearing down the tissue.

SPEAKER_00

Which gives you a 20-year window to intervene.

SPEAKER_01

Precisely. But moving to the older demographic, late life depression behaves entirely differently. That is the check engine light.

SPEAKER_00

Aaron Powell Right, because if you're over 60 and you develop new depressive symptoms and then get dementia a few years later, the depression didn't cause the dementia in that short time frame.

SPEAKER_01

Aaron Powell Exactly. The timeline just doesn't support the biological wear and tear model. Instead, it serves as a warning sign that neurodegenerative pathology is already actively progressing.

SPEAKER_00

It's disrupting the mood centers before the memory loss even becomes obvious. Spot on. So we know the rust is destroying the car for people in their 50s. But that still doesn't explain why some cars rust faster than others in the exact same environment.

Genetics Flip The Expected Risk

SPEAKER_01

No, it doesn't.

SPEAKER_00

Two people can have severe midlife depression, yet only one develops dementia. Which brings us to the second key the researchers used, the genetic blueprints.

SPEAKER_01

Right, because not all brains start from the same baseline of vulnerability. They analyze the participants' DNA to understand how innate susceptibility interacts with the stress of depression.

SPEAKER_00

Here's where it gets really interesting. Because when I initially read this part, I made a major assumption.

SPEAKER_01

What did you assume?

SPEAKER_00

Logically, if you have a high genetic risk for Alzheimer's and you suffer from chronic depression, your chances of getting dementia should go absolutely off the charts, right? Like adding fuel to a fire.

SPEAKER_01

Aaron Ross Powell It makes sense intuitively. You'd think taking a vulnerable brain and bombarding it with cortisol would be disastrous. But what's fascinating here is that the empirical data revealed the exact opposite phenomenon.

SPEAKER_00

Wait, really?

SPEAKER_01

Yeah. The researchers used an Alzheimer's polygenic risk score, or PRS. Unlike older studies that might just look for a single genetic mutation, a polygenic score analyzes a vast network of genetic variants to calculate an aggregate risk profile.

SPEAKER_00

Okay. And they found that depression strongly predicted incident dementia only among individuals with a lower genetic risk for Alzheimer's.

SPEAKER_01

The contrast was incredibly sharp, particularly in that midlife group. For individuals under 60 who had a low genetic risk for Alzheimer's, experiencing depressive symptoms was associated with a massive 2.7-fold higher incidence of dementia.

SPEAKER_00

That is nearly three times the baseline risk.

SPEAKER_01

It is. Meanwhile, for the individuals in that same age group who carried a high genetic risk, the impact of depression on their relative dementia risk was near-null. It barely registered.

SPEAKER_00

So if I do not have the genetic coding for Alzheimer's, depression increases my risk by 270%. But if I do have the genes, depression barely moves the needle.

SPEAKER_01

That's what the data shows.

SPEAKER_00

To understand that, we have to look past the math and examine the biology. Let's picture the genetic risk like a ship navigating the ocean.

SPEAKER_01

Okay.

SPEAKER_00

If the hull of your ship is already ripped wide open by high genetic susceptibility, meaning pathways for amyloid plaques and tau tangles are genetically hardwired to occur. Well, your ship is going down. Right. Having a broken water pump, which represents the depression, doesn't fundamentally alter the outcome. The primary biological drivers are already overwhelming the system.

SPEAKER_01

That is exactly it. Conversely, if you have a low genetic risk, your hull is perfectly intact. The innate genetic drivers of Alzheimer's are absent.

SPEAKER_00

So the broken water pump becomes the main problem.

SPEAKER_01

Yes. In these individuals, the chronic depression suddenly becomes a highly potent alternative pathway to sinking the ship. The inflammation, the cortisol toxicity, the vascular damage, they become the primary engines driving the brain toward dementia.

SPEAKER_00

So depression isn't just an incidental factor for the low-risk group, it is the central mechanism of their decline.

SPEAKER_01

Exactly. And for the science buffs listening, it's worth noting, the researchers looked specifically at the famous APOE Epsilon-4 gene.

SPEAKER_00

Aaron Ross Powell Right, the most well-known Alzheimer's gene.

SPEAKER_01

Yeah. And that single gene on its own did not modify this overall risk. The paradoxical effect only emerged when they looked at the broader, comprehensive polygenic risk score.

SPEAKER_00

Aaron Ross Powell Because single gene analysis is kind of outdated for these complex conditions, right? Alzheimer's is a network problem, not a single light switch.

SPEAKER_01

Exactly. A polygenic score provides a much more accurate map of vulnerability because it accounts for thousands of tiny genetic variations.

SPEAKER_00

Aaron Powell Okay, so we clearly see how depression massively impacts people with low genetic risk. But that leaves a glaring question about the people who do have a high genetic risk.

SPEAKER_01

Yeah, what's going on with them?

SPEAKER_00

Aaron Powell If depression doesn't add much extra relative deranger, does the presence of depression still communicate something clinically important for them?

SPEAKER_01

Aaron Powell It communicates a profound amount of information, but we have to shift how we track disease progression.

Mapping Decline With Markov Stages

SPEAKER_01

The researchers used a multi-state Markov model for this.

SPEAKER_00

Aaron Powell And a Markov model tracks the entire journey rather than just a snapshot of the start and end points, right?

SPEAKER_01

Trevor Burrus Exactly. Instead of just noting who was healthy in 1998 and who had dementia in 2020, it maps the specific transitions through different stages of cognitive decline over those 22 years.

SPEAKER_00

Aaron Powell And it accounts for bidirectional movement too. Like patients can deteriorate, but depending on the stage, they can also revert and stabilize.

SPEAKER_01

Right. So the researchers mapped out the journec cognitive stages using the Lang-Aweir algorithm.

SPEAKER_00

Aaron Powell And that algorithm mathematically combines formal memory test scores with daily functioning metrics, like managing finances.

SPEAKER_01

Yeah. So stage one is normal cognition. Stage two is subjective memory complaint or SMC. Stage three is cognitive impairment, no dementia, or CIND, and the final stage is full dementia.

SPEAKER_00

Aaron Powell Okay, let's focus on that second stage subjective memory complaint or SMC. That is a highly controversial clinical gray area.

SPEAKER_01

It really is.

SPEAKER_00

It's the stage where a patient acutely recognizes their own cognitive slippage, but their formal diagnostic tests are still completely normal.

SPEAKER_01

Right. The clinical biomarkers are quietly accumulating, but the outward metrics are clean. The tests say you're fine, but you know your brain is betraying you. Terrifying. It is. And integrating depression into this Markov model yielded some sobering data. Across all genetic profiles, depression actively accelerates forward transitions. For instance, jumping from the SMC stage to the more severe CIND stage goes up by 33% if they are currently experiencing depression.

SPEAKER_00

And it sabotages recovery too, right? It drastically reduces the chances of a patient in the SMC stage reverting back to normal cognition.

SPEAKER_01

Exactly. But the most revealing aspect of this model is what we call the prodrome proof. They discovered that carrying a high polygenic risk score was positively associated with a significant surge in depressive symptoms, specifically at the subjective memory complaint stage.

SPEAKER_00

Wait, let's trace the logic there. If you possess the genetic coding for Alzheimer's, you are statistically engineered to experience a massive spike in clinical depression at the exact physiological moment your memory subjectively begins to slip.

SPEAKER_01

Yes. That association did not exist when those high-risk individuals were in the normal cognition stage, nor did it exist once they hit full-blown dementia. It strictly manifested within that transitional SMC twilight zone.

SPEAKER_00

We have to completely reevaluate our assumptions about aging to grasp this. When an older parent begins forgetting things and falls into a deep depression, our immediate compassionate instinct is to view it as a psychological reaction.

SPEAKER_01

Right. We assume they're grieving their independence or reacting to the frustration of memory loss.

SPEAKER_00

But the data here actively dismantles that psychological reaction theory, because if it was simply a normal emotional response to forgetting things, every participant experiencing SMC would have equal rates of depression.

SPEAKER_01

But they don't. The individuals who develop profound depression at that exact stage are overwhelmingly the ones carrying the high genetic risk for Alzheimer's.

SPEAKER_00

Which points directly to an underlying physical mechanism.

SPEAKER_01

Exactly. For highly susceptible older adults, getting depressed alongside subjective memory slips is the prodromal signal. The neurodegenerative processes, the toxic proteins, they physically disrupt the white matter tracks connecting the brain's mood-regulating centers, like the graphing nuclei, long before the memory centers are destroyed.

SPEAKER_00

Aaron Powell So the mood disorder and the cognitive decline are co-emerging from the exact same physical tissue degradation.

SPEAKER_01

Yes. The diagnostic scans might not be sensitive enough to show the structural dementia yet, but the sudden onset of depression is the biological check engine light flashing.

SPEAKER_00

Aaron Powell That is just incredible.

What To Do By Age

SPEAKER_00

So what does this all mean? When we strip away all the hazard ratios on the models, what are the actionable takeaways for you listening right now?

SPEAKER_01

Aaron Powell Well, there are two distinct mandates depending on where you are in your lifespan.

SPEAKER_00

Right. First, if you or a loved one are in your 50s, actively treating and managing middle depression is not merely a psychological intervention to feel better today, not at all. It is a critical, highly modifiable biological action to protect your physical brain from dementia decades down the line, especially if you do not have a family history of Alzheimer's.

SPEAKER_01

That midlife window is where prevention holds the most power. By treating the mood disorder, you're effectively stopping the rust from corroding your brain. You are removing the primary engine of decline for those with low genetic risk.

SPEAKER_00

And the second mandate applies to the older demographic. If you are in your late 60s or 70s and begin noticing subjective memory slips, those SMC moments accompanied by new depressive symptoms, it can never be brushed off as just getting older.

SPEAKER_01

It demands an immediate shift in strategy. That pairing requires rigorous monitoring by a doctor, potentially initiating early interventions or screenings for underlying pathology. We have to stop treating late-life depression in a diagnostic vacuum.

SPEAKER_00

This raises an important question regarding our relationship with our own biology, really.

SPEAKER_01

It does.

SPEAKER_00

Yeah.

SPEAKER_01

Because the true value of untangling this medical mystery lies in application. We can't alter our DNA, but understanding how our genetics interact with our mental health across our timeline gives us immense agency. Right. It provides the precise context needed to know when we must fight depression as an active cause of brain damage and when we must carefully heat it as a symptom of a deeper decline.

SPEAKER_00

Which leaves a final provocative thought for you to consider as we close this deep dive. If effectively treating midlife depression physically fortifies the brain's resilience against dementia decades later, should we completely dismantle the artificial wall between mental health and physical neurology in our healthcare system?

SPEAKER_01

It's a great question.

SPEAKER_00

For centuries, medicine has treated the mind and the brain as if they reside in completely different buildings of the hospital. But if this longitudinal data proves anything, it is that the mind and the brain are the exact same vulnerable tissue. Could the therapy session you attend today, or the antidepressant you take tomorrow, actually serve as the physical armor that saves your memory twenty years from now? Something to mull over the next time you evaluate the true importance of your own mental health.